Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Robert Scheinman to Rats

This is a "connection" page, showing publications Robert Scheinman has written about Rats.

 
Connection Strength
 
 
 
0.217
 
  1. Kupfer R, Lang J, Williams-Skipp C, Nelson M, Bellgrau D, Scheinman RI. Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Mol Immunol. 2007 Jan; 44(4):479-87.
    View in: PubMed
    Score: 0.034
  2. Li Y, Jacques S, Gaikwad H, Nebbia M, Banda NK, Holers VM, Tomlinson SA, Scheinman RI, Monte A, Saba L, Lasda E, Hasselberth J, Busquet N, Zelek WM, Moghimi SM, Simberg D. Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. Sci Adv. 2025 Jul 11; 11(28):eadw1731.
    View in: PubMed
    Score: 0.032
  3. Lang JA, Kominski D, Bellgrau D, Scheinman RI. Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation. Eur J Immunol. 2004 Sep; 34(9):2396-406.
    View in: PubMed
    Score: 0.030
  4. Li Y, Jacques S, Gaikwad H, Wang G, Banda NK, Holers VM, Scheinman RI, Tomlinson S, Moghimi SM, Simberg D. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nat Nanotechnol. 2024 Feb; 19(2):246-254.
    View in: PubMed
    Score: 0.028
  5. Kupfer R, Scheinman RI. Measurement of IKK activity in primary rat T cells: rapid activation and inactivation. J Immunol Methods. 2002 Aug 01; 266(1-2):155-64.
    View in: PubMed
    Score: 0.026
  6. Li Y, Wang G, Griffin L, Banda NK, Saba LM, Groman EV, Scheinman R, Moghimi SM, Simberg D. Complement opsonization of nanoparticles: Differences between humans and preclinical species. J Control Release. 2021 10 10; 338:548-556.
    View in: PubMed
    Score: 0.025
  7. Thakur A, Scheinman RI, Rao VR, Kompella UB. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res. 2011 Nov; 82(3):346-50.
    View in: PubMed
    Score: 0.012
  8. Scheinman RI, Auld VJ, Goldin AL, Davidson N, Dunn RJ, Catterall WA. Developmental regulation of sodium channel expression in the rat forebrain. J Biol Chem. 1989 Jun 25; 264(18):10660-6.
    View in: PubMed
    Score: 0.011
  9. Luckey SW, Taylor M, Sampey BP, Scheinman RI, Petersen DR. 4-hydroxynonenal decreases interleukin-6 expression and protein production in primary rat Kupffer cells by inhibiting nuclear factor-kappaB activation. J Pharmacol Exp Ther. 2002 Jul; 302(1):296-303.
    View in: PubMed
    Score: 0.006
  10. Moore JK, Scheinman RI, Bellgrau D. The identification of a novel T cell activation state controlled by a diabetogenic gene. J Immunol. 2001 Jan 01; 166(1):241-8.
    View in: PubMed
    Score: 0.006
  11. Scheller A, Scheinman RI, Thompson E, Scarlett CO, Robins DM. Contextual dependence of steroid receptor function on an androgen-responsive enhancer. Mol Cell Endocrinol. 1996 Jul 23; 121(1):75-86.
    View in: PubMed
    Score: 0.004
  12. Wollner DA, Scheinman R, Catterall WA. Sodium channel expression and assembly during development of retinal ganglion cells. Neuron. 1988 Oct; 1(8):727-37.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)